Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature

Schizophrenia Research

Volumn 22, Issue 2, 1996, Pages 133-141

  Dalack, Gregory W ^a,b   Meador Woodruff, James H ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

dopamine; glutamate; nicotine; schizophrenia; smoking

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING CESSATION;

EID: 0030588986     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)80441-5     Document Type: Article

References (46)

1. Adler, L.E., Hoffer, L.D., Wiser, A. and Freedman, R. (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150, 1856-1861.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Association, Washington, DC.
3. Benowitz, N.L. (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med. 319, 1318-1330.
4. Collins, A.C., Bhat, R.V., Pauly, J.R. and Marks, M.J. (1990) Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In: G. Bock (Ed.), The Biology of Nicotine Dependence. New York, NY, pp. 68-82.
5. Davis, K.L., Kahn, R.S., Ko, G. and Davidson, M. (1991) Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148, 1474-1486.
6. Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S. and Scapicchio, P. (1990) Cigarette smoking and neuroleptic-induced parkinsonism. Biol. Psychiatry 28, 502-508.
7. de Leon, J., Dadvand, M., Canuso, C., White, A.O., Stanilla, J.K. and Simpson, G.M. (1995) Schizophrenia and smoking: An epidemiological survey in a state hospital. Am. J. Psychiatry 152, 453-455.
8. Di Chiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85, 5274-5278.
9. Eastwood, R. (1993) Weeding out. Lancet 341, 1316.
10. El-Guebaly, N. and Hodgins, D.C. (1992) Schizophrenia and substance abuse: Prevalence issues. Can. J. Psychiatry 37. 704-710.
11. Ereshefsky, L., Jann, M.W., Saklad, S.R., Davis, C.M., Richards, A.L. and Burch, N.R. (1985) Effects of smoking on fluphenazine clearance in psychiatric inpatients. Biol. Psychiatry 20, 329-332.
12. Fagerstrom, K.-O., Lunell, E. and Molander, L. (1991) Continuous and intermittent transdermal delivery of nicotine: Blockade of withdrawal symptoms and side effects. J. Smoking-Related Dis. 2, 173-180.
13. Glassman, A.H. (1993) Cigarette smoking: Implications for psychiatric illness. Am. J. Psychiatry 150, 546-553.
14. Glassman, A.H., Covey, L.S., Dalack, G.W., Stetner, F., Rivelli, S.K., Fleiss, J. and Cooper, T.B. (1993) Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin. Pharmacol. Ther. 54, 670-679.
15. Glynn, S.M. and Sussman, S. (1990) Why patients smoke (letter). Hosp. Community Psychiatry 41, 1027-1028.
16. Goff, D.C., Henderson, D.C. and Amico, E. (1992) Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am. J. Psychiatry 149, 1189-1194.
17. Gorsline, J., Benowitz, N.L., Rolf, C.N., Gupta, S.K. and Garaud, J.J. (1992) Comparison of plasma nicotine concentrations for nicotine transdermal system (NTS), cigarette smoking and nicotine polacrilex (nicotine gum). Abstract. Clin. Pharmacol. Ther. 51, 129.
18. Greeman, M. and McClellan, T.A. (1991) Negative effects of a smoking ban on an inpatient psychiatry service. Hosp. Commun. Psychiatry 42, 408-412.
19. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C. and Fagerstrom, K.-O. (1991) The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br. J. Addiction 86, 1119-1127.
20. Hughes, J.R., Hatsukami, D.K., Mitchell, J.E. and Dahlgren, L.A. (1986) Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143, 993-997.
21. Imperato, A., Mulas, A. and Di Chiara, G. (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132, 337-338.
22. Jann, M.W., Saklad, S.R., Ereshefsky, L., Richards, A.L., Harrington, C.A. and Davis, C.M. (1986) Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology 90, 468-470.
23. Kirch, D.G., Gerhardt, G.A., Shelton, R.C., Freedman, R. and Wyatt, R.J. (1987) Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clin. Neuropharmacol. 10, 376-383.
24. Lohr, J.B. and Flynn, K. (1992) Smoking and schizophrenia. Schizophr. Res. 8, 93-102.
25. Masterson, E. and O'Shea, B. (1984) Smoking and malignancy in schizophrenia. Br. J. Psychiatry 145, 429-432.
26. McEvoy, J.P., Freudenreich, O., Levin, E.D. and Rose, J.E. (1995a) Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119, 124-126.
27. McEvoy, J., Freudenreich, O., McGee, M., VanderZwaag, C., Levin, E. and Rose, J. (1995b) Clozapine decreases smoking in patients with chronic schizophrenia. Biol. Psychiatry 37, 550-552.
28. Menza, M.A., Grossman, N., Van Horn, M., Cody, R. and Forman, N. (1991) Smoking and movement disorders in psychiatric patients. Biol. Psychiatry 30, 109-115.
29. Morens, D.M., Grandinetti, A., Reed, D., White, L.R. and Ross, G.W. (1995) Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45, 1041-1051.
30. Overall, J.E. and Gorham, D.R. (1962) The Brief Psychiatric Rating Scale. Psychol. Rep. 10, 799-812.
31. Palmer, K.J., Buckley, M.M. and Faulds, D. (1992) Transdermal nicotine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 44, 498-529.
32. Perry, P.J., Miller, D.D., Arndt, S.V., Smith, D.A. and Holman, T.L. (1993) Haloperidol dosing requirements: The contribution of smoking and nonlinear pharmacokinetics. J. Clin. Psychopharmacol. 13, 46-51.
33. Sandyk, R. (1993) Cigarette smoking: Effects on cognitive functions and drug-induced Parkinsonism in chronic schizophrenia. Int. J. Neurosci. 70, 193-197.
34. Sandyk, R. and Kay, S.R. (1991) Tobacco addiction as a marker of age at onset of schizophrenia. Int. J. Neurosci. 57, 259-262.
35. Schneier, F.R. and Siris, S.G. (1987) A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. J. Nerv. Ment. Dis. 175, 641-652.
36. Spitzer, R.L., Williams, J.B.W., Gibbon, M. and First, M.B. (1989) Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P, 9/1/89 Version). Biometrics Research Department, New York State Psychiatric Institute. New York, NY.
37. Toth, E., Sershen, H., Hashim, A., Vizi, E.S. and Lajtha, A. (1992) Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid. Neurochem. Res. 17, 265-271.
38. Tung, C.-S., Grenhoff, J. and Svensson, T.H. (1990) Nicotine counteracts midbrain dopamine cell dysfunction induced by prefrontal cortex inactivation. Acta Physiol. Scand. 138, 427-428.
39. Vidal, C. (1994) Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex: New insight into the analysis of the role of nicotinic receptors in cognitive functions. Drug Dev. Res. 31, 120-126.
40. Warburton, D.M. (1987) The functions of smoking. Adv. Behav. Biol. 31, 51-61.
41. Weinberger, D.R., Berman, K.F. and Illowsky, B.P. (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, III: a new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45, 609-615.
42. Wesnes, K. and Warburton, D.M. (1983) Smoking, nicotine and human performance. Pharmacol. Ther. 21, 189-208.
43. Wirshing, W.C., Engle, J., Levin, E., Cummings, J.L. and Rose, J. (1989) The acute effects of smoking on tardive dyskinesia. In: New Research Program and Abstracts, 142nd Annual Meeting of the American Psychiatric Association, San Francisco, CA.
44. Wonnacott, S., Draso, A., Sanderson, E. and Rowell, P. (1990) Presynaptic nicotinic receptors and the modulation of transmitter release. In: G. Bock (Ed.), The Biology of Nicotine Dependence. Plenum, New York, NY, pp. 87-101.
45. Yassa, R., Lal, S., Korpassy, A. and Ally, J. (1987) Nicotine exposure and tardive dyskinesia. Biol. Psychiatry 22, 67-72.
46. Ziedonis, D.M., Kosten, T.R., Glazer, W.M. and Frances, R.J. (1994) Nicotine dependence and schizophrenia. Hosp. Commun. Psychiatry 45, 204-206.